NFKB1 and neoplasm: The ability of PYCRs to modulate pathways such as the G2M checkpoint and E2F targets, essential for cell cycle regulation and tumor proliferation [34,35], contrasts sharply with their negative regulation of immune-related pathways like TNF-α signaling, NF-κB activation, and interferon-gamma response critical for anti-tumor immunity [36].